[与年龄相关的黄斑变性神经保护疗法]
A S Vlasova1, S A Petrov1,2, E V Renzyak1,3
1West Siberian Institute of Postgraduate Medical Education, Tyumen, Russia.
Vestnik oftalmologii
|December 28, 2024
概括
与年龄相关的黄斑变性 (AMD) 由于光受体细胞死亡导致不可逆转的失明. 本文审查了AMD的研究.
科学领域:
- 眼科医生 眼科 眼科
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
背景情况:
- 与年龄相关的黄斑变性 (AMD) 是全球不可逆转失明的主要原因.
- 具有影响视网膜的慢性多因素病理过程的特征.
- 光受体退化是一个关键特征,但确切的机制仍在争论中.
研究的目的:
- 审查AMD中光受体退化的病理生理机制.
- 总结AMD治疗干预的科学进展.
- 突出在AMD中视网膜神经保护的潜在药理策略.
主要方法:
- 国际和俄罗斯研究的综合文献综述.
- 对AMD中的分子和细胞破坏数据的分析.
- 评估当前和新兴的治疗方法.
主要成果:
- 确定了导致光受体死亡的关键分子和细胞干扰.
- 总结了现有的治疗策略及其局限性.
- 突出显示有希望但尚未经过临床验证的神经保护剂.
结论:
- 了解AMD复杂的病理生理学对于有效治疗至关重要.
- 药理上视网膜神经保护具有潜力,但需要进一步的临床验证.
- 需要继续进行研究,以开发AMD的最终疗法.
更多相关视频
10:24Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
10.0K
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
1.9K
相关概念视频
01:22Alzheimer's Disease: Treatment
125
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
125
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K